Univo IRB is your next generation institutional review board (IRB) company specializing in ethical review of Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research. We offer agile, expert solutions powered by forward-thinking technology and a service-first approach.
We respect all, harm no one, and protect the welfare of everyone we can. Never satisfied with the bare minimum, we work tirelessly to be the best at unifying participants with researchers so that everyone has the access to, right to, and benefit of research.
What Does Univo IRB Mean?
Univo IRB (You-Nih-Voh)
We seek to unite research stakeholders with the voice of the research participant.
The individual participant is our guiding light and protecting them is our goal.
Our Mission
Unifying research with our passion for patient participation, education, and advocacy.
Our Vision
To create a future where everyone realizes the opportunities available to them in research.
Our Values
In everything we do, we are:
Fast
We understand the importance of quick responses and offer an agile approach for timely reviews.
Friendly
We are research professionals you want to work with, focusing on service to provide you a simplified IRB experience.
Fair
With reasonable pricing and complete reliability, we deliver total peace of mind.
The Univo IRB Story
2016
- Principal IRB, LLC is founded by two individuals determined to bring the principles of human research protection back to the IRB review service industry
2020
- Principal IRB receives full AAHRPP accreditation
2023
- Principal IRB receives full AAHRPP reaccreditation for 5 years
- QHP Capital acquires Principal IRB and invests in experienced IRB leadership and new technology
2024
- Principal IRB evolves into Univo IRB, demonstrating our commitment to being your one and only IRB and representing our pledge to protect patients while acting as their voice in research
- Univo launches OneVerseTM
- Univo expands to conducting reviews in Canada
